查找临床试验
已按「淋巴瘤」检索，对应国际通用词 lymphoma
共找到 1,082 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 22:08，每 5 分钟自动同步A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
United States
年龄 18 Years – 不限
Lyell Immunopharma, Inc.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
United States、Puerto Rico
年龄 18 Years – 80 Years
VM Oncology, LLC
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
United States
年龄 不限 – 30 Years
Washington University School of Medicine
Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia
Denmark
年龄 1 Year – 45 Years
Copenhagen University Hospital, Rigshospitalet
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
United States、Bosnia and Herzegovina、Bulgaria、Croatia、Hungary 等 8 国
年龄 18 Years – 不限
Grifols Therapeutics LLC
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
South Korea
年龄 1 Year – 19 Years
Jae Wook Lee
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
United States
年龄 18 Years – 不限
Memorial Sloan Kettering Cancer Center
Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain
Spain
年龄 18 Years – 不限
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
United States、Australia、Belgium、Denmark、Italy
年龄 18 Years – 不限
Incyte Corporation
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
United States
年龄 18 Years – 不限
Yazeed Sawalha
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
Italy
年龄 18 Years – 不限
Fondazione Italiana Linfomi - ETS
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
United States
年龄 3 Months – 30 Years
University of Colorado, Denver